Attention, Canberra residents! Getting ADHD medication just got a whole lot easier. In a move that’s set to shake up the healthcare landscape, appropriately trained Canberra GPs can now prescribe ADHD medications without requiring patients to repeatedly see specialists. But here’s where it gets even more groundbreaking: this change isn’t just about convenience—it’s about breaking down barriers that have long frustrated families and individuals living with ADHD. And this is the part most people miss: it’s not just about skipping specialist reviews; it’s about empowering GPs to take a central role in ADHD care, while still maintaining crucial safeguards.
For years, eligible patients have had to endure repeated reviews by psychiatrists, paediatricians, or neurologists just to access their medication. Now, if you’re stable on your ADHD medication, aged six or older, and have an existing specialist diagnosis, your GP can handle the prescribing—no more bureaucratic hoops. Even more surprising? GPs won’t need approval from the Chief Health Officer to continue prescribing. Controversial? Some might argue this shifts too much responsibility onto GPs, but Health Minister Rachel Stephen-Smith sees it as a win-win: fewer delays, less demand for specialist appointments, and less administrative burden for everyone involved.
But here’s the twist: while GPs gain more autonomy, specialists like psychiatrists, paediatricians, and neurologists will now need approval from the Chief Health Officer to prescribe ADHD medications within specific dosage ranges. Is this a step too far, or a necessary balance? The Australian Medical Association (AMA) ACT president, Dr. Kerrie Aust, calls it a “sensible reform,” praising its alignment with clinical realities and patient needs. Yet, the question remains: will this change truly streamline care, or will it create new challenges?
For those GPs who aren’t ready to take on this expanded role, there’s still a middle ground: they can prescribe ADHD medications in a shared-care arrangement with specialists. And with ADHD affecting an estimated 6 to 10% of Australian children and young people, and 2 to 10% of adults, these changes couldn’t come at a better time. Royal Australian College of GPs (RACGP) NSW&ACT chair Dr. Rebekah Hoffman highlights the tangible benefits: shorter wait times, consistent care, and better access for families who’ve long struggled with the system.
But here’s the bigger picture: this is just the beginning. Later this year, further reforms will allow GPs with additional training to diagnose ADHD and initiate medication—a move that’s been called “overdue” by Dr. Hoffman. “GPs are already well-equipped to manage chronic conditions,” she explains. “ADHD isn’t radically different, and our role in providing holistic, ongoing care makes us perfectly suited to support these patients.”
So, what do you think? Is this a much-needed reform, or are we moving too fast? Will GPs truly be able to handle the expanded responsibilities, or are we risking patient safety? Share your thoughts in the comments—this conversation is far from over.
For more information, visit the ACT Government’s ADHD care page (https://www.act.gov.au/health/mental-health-care/adhd-care-in-the-act) or HealthDirect’s ADHD resources (https://www.healthdirect.gov.au/attention-deficit-disorder-add-or-adhd).
